Literature DB >> 18061303

Current state and future directions of pleural mesothelioma imaging.

Samuel G Armato1, James Entwisle, Mylene T Truong, Anna K Nowak, Giovanni Luca Ceresoli, Binsheng Zhao, Ripen Misri, Hedy L Kindler.   

Abstract

The diagnosis, staging, and response assessment of mesothelioma pose unique challenges to radiologic imaging. No single, conventional imaging approach captures the information necessary to direct all aspects of patient management. Instead, the complexities of this unique disease demand the integration of elements cleverly adapted from different modalities. Imaging-based studies presented at the 8th International Conference of the International Mesothelioma Interest Group (IMIG) in October 2006 sought to further define the current practice and future potential of radiology for the mesothelioma patient. The imaging studies selected through a peer-review process for presentation at the 2006 IMIG Conference were intended to frame this research in the context of the unique imaging challenges presented by mesothelioma while stimulating dialogue on the future resolution of these challenges. This communication conveys the pitfalls and potential of pleural mesothelioma imaging based on work presented at the Conference. From diagnosis to response, PET/CT to molecular bioprobes, volumetric analysis to computerized tumor assessment, imaging promises to provide valuable insight for patients with mesothelioma and the physicians who treat them.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18061303     DOI: 10.1016/j.lungcan.2007.09.027

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  9 in total

1.  Positron emission tomography in mesothelioma patients.

Authors:  Gaia Grassetto; Domenico Rubello
Journal:  Mol Imaging Biol       Date:  2009-03-25       Impact factor: 3.488

2.  Optimization of response classification criteria for patients with malignant pleural mesothelioma.

Authors:  Zacariah E Labby; Samuel G Armato; Hedy L Kindler; James J Dignam; Arman Hasani; Anna K Nowak
Journal:  J Thorac Oncol       Date:  2012-11       Impact factor: 15.609

Review 3.  Current evidence base of FDG-PET/CT imaging in the clinical management of malignant pleural mesothelioma: emerging significance of image segmentation and global disease assessment.

Authors:  Sandip Basu; Babak Saboury; Drew A Torigian; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

4.  Preliminary study of positron emission tomography/computed tomography and plasma osteopontin levels in patients with asbestos-related pleural disease.

Authors:  Seiji Kurata; Masatoshi Ishibashi; Koichi Azuma; Hayato Kaida; Shinzo Takamori; Kiminori Fujimoto; Maiko Kobayashi; Yasumitsu Hirose; Hisamichi Aizawa; Naofumi Hayabuchi
Journal:  Jpn J Radiol       Date:  2010-07-27       Impact factor: 2.374

5.  Massive localized malignant pleural mesothelioma (LMPM): manifestations on computed tomography in 6 cases.

Authors:  Weigen Yao; Hanqing Yang; Guolai Huang; Yang Yan; Honglin Wang; Dongfang Sun
Journal:  Int J Clin Exp Med       Date:  2015-10-15

6.  Computed tomography features of local pleural recurrence in patients with malignant pleural mesothelioma treated with intensity-modulated pleural radiation therapy.

Authors:  Darragh Halpenny; Micheal Raj; Andreas Rimner; Junting Zheng; Marinela Capanu; Michelle S Ginsberg
Journal:  Eur Radiol       Date:  2019-01-28       Impact factor: 5.315

Review 7.  Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group.

Authors:  Samuel G Armato; Kevin G Blyth; Jane J Keating; Sharyn Katz; Selina Tsim; Johan Coolen; Eyjolfur Gudmundsson; Isabelle Opitz; Anna K Nowak
Journal:  Lung Cancer       Date:  2016-09-05       Impact factor: 5.705

8.  Computer-aided volumetric assessment of malignant pleural mesothelioma on CT using a random walk-based method.

Authors:  Mitchell Chen; Emma Helm; Niranjan Joshi; Fergus Gleeson; Michael Brady
Journal:  Int J Comput Assist Radiol Surg       Date:  2016-12-27       Impact factor: 2.924

Review 9.  Malignant mesothelioma.

Authors:  Alastair J Moore; Robert J Parker; John Wiggins
Journal:  Orphanet J Rare Dis       Date:  2008-12-19       Impact factor: 4.123

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.